Table 2 Comparison of results of RT-qPCR and IHC/FISH methods used in assessment of ALK rearrangements.
From: Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement
Number of cases | ||
|---|---|---|
RT PCR positive | RT PCR negative | |
FISH and IHC positive | 16 | 6 |
FISH and IHC negative | 3 | 76 |
